306 related articles for article (PubMed ID: 23957734)
1. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
Tursi A; Brandimarte G; Elisei W; Picchio M; Forti G; Pianese G; Rodino S; D'Amico T; Sacca N; Portincasa P; Capezzuto E; Lattanzio R; Spadaccini A; Fiorella S; Polimeni F; Polimeni N; Stoppino V; Stoppino G; Giorgetti GM; Aiello F; Danese S
Aliment Pharmacol Ther; 2013 Oct; 38(7):741-51. PubMed ID: 23957734
[TBL] [Abstract][Full Text] [Related]
2. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W
J Clin Gastroenterol; 2006 Apr; 40(4):312-6. PubMed ID: 16633103
[TBL] [Abstract][Full Text] [Related]
3. Mesalazine and/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W
Hepatogastroenterology; 2008; 55(84):916-20. PubMed ID: 18705297
[TBL] [Abstract][Full Text] [Related]
4. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
Picchio M; Elisei W; Tursi A
J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
[TBL] [Abstract][Full Text] [Related]
5. Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study.
Kruis W; Meier E; Schumacher M; Mickisch O; Greinwald R; Mueller R;
Aliment Pharmacol Ther; 2013 Apr; 37(7):680-90. PubMed ID: 23414061
[TBL] [Abstract][Full Text] [Related]
6. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
[TBL] [Abstract][Full Text] [Related]
7. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
[TBL] [Abstract][Full Text] [Related]
8. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
Picchio M; Elisei W; Brandimarte G; Di Mario F; Malfertheiner P; Scarpignato C; Tursi A
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S64-9. PubMed ID: 27622370
[TBL] [Abstract][Full Text] [Related]
9. Intermittent versus every-day mesalazine therapy in preventing complications of diverticular disease: a long-term follow-up study.
Tursi A; Di Mario F; Brandimarte G; Elisei W; Picchio M; Loperfido S; Dal Bo' N; Ferrara F; Marcello R; Heras Salvat H; Scarpignato C
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3244-8. PubMed ID: 24338468
[TBL] [Abstract][Full Text] [Related]
10. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.
Comparato G; Fanigliulo L; Cavallaro LG; Aragona G; Cavestro GM; Iori V; Maino M; Mazzocchi G; Muzzetto P; Colla G; Sianesi M; Franzé A; Mario FD
Dig Dis Sci; 2007 Nov; 52(11):2934-41. PubMed ID: 17410435
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
[TBL] [Abstract][Full Text] [Related]
12. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.
Brandimarte G; Tursi A
Med Sci Monit; 2004 May; 10(5):PI70-3. PubMed ID: 15114281
[TBL] [Abstract][Full Text] [Related]
13. Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.
Kruis W; Kardalinos V; Eisenbach T; Lukas M; Vich T; Bunganic I; Pokrotnieks J; Derova J; Kondrackiene J; Safadi R; Tuculanu D; Tulassay Z; Banai J; Curtin A; Dorofeyev AE; Zakko SF; Ferreira N; Björck S; Diez Alonso MM; Mäkelä J; Talley NJ; Dilger K; Greinwald R; Mohrbacher R; Spiller R
Aliment Pharmacol Ther; 2017 Aug; 46(3):282-291. PubMed ID: 28543263
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
[TBL] [Abstract][Full Text] [Related]
15. Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W
Dig Dis Sci; 2007 Mar; 52(3):671-4. PubMed ID: 17253134
[TBL] [Abstract][Full Text] [Related]
16. Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration.
Parente F; Bargiggia S; Prada A; Bortoli A; Giacosa A; Germanà B; Ferrari A; Casella G; De Pretis G; Miori G;
Int J Colorectal Dis; 2013 Oct; 28(10):1423-31. PubMed ID: 23754545
[TBL] [Abstract][Full Text] [Related]
17. Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease.
Cuomo R; Cargiolli M; Andreozzi P; Zito FP; Sarnelli G
Minerva Gastroenterol Dietol; 2017 Jun; 63(2):130-142. PubMed ID: 27973463
[TBL] [Abstract][Full Text] [Related]
18. Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study.
Marteau P; Crand J; Foucault M; Rambaud JC
Gut; 1998 Feb; 42(2):195-9. PubMed ID: 9536943
[TBL] [Abstract][Full Text] [Related]
19. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.
Gatta L; Di Mario F; Curlo M; Vaira D; Pilotto A; Lucarini P; Lera M; Enkleda K; Franzé A; Scarpignato C
Intern Emerg Med; 2012 Apr; 7(2):133-7. PubMed ID: 21279478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
